Google has announced a new advertising policy for pharmaceutical companies that presents significant issues and dictates immediate changes. Effective July 20, pharmaceutical companies can no longer run pharmaceutical ads in the so-called “Black Box Ad Format” – a format that had previously been approved by the FDA. Instead, pharmaceutical companies will now have to run
FDA Knows Time Is Running Out on Internet and Social Media Guidance
In a recent interview published by Pharmalot, the Director of the FDA Office of Prescription Drug Promotion (OPDP), Thomas Abrams, indicated that the long-waited draft guidance on the promotion of medical products using the Internet and social media is forthcoming. According to Abrams: “The development and issuance of guidance for social media is among the highest of FDA’s priorities.”
With other agencies issuing social media guidance over the past year (e.g., FTC, SEC), it is hard not to believe Abrams. However, some skepticism is warranted because the industry has been waiting for FDA’s promises about forthcoming Internet-related guidance for almost two decades now…
Continue Reading FDA Knows Time Is Running Out on Internet and Social Media Guidance